1. Home
  2. AZTA vs JBGS Comparison

AZTA vs JBGS Comparison

Compare AZTA & JBGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTA
  • JBGS
  • Stock Information
  • Founded
  • AZTA 1978
  • JBGS 2016
  • Country
  • AZTA United States
  • JBGS United States
  • Employees
  • AZTA N/A
  • JBGS N/A
  • Industry
  • AZTA Industrial Machinery/Components
  • JBGS Real Estate Investment Trusts
  • Sector
  • AZTA Technology
  • JBGS Real Estate
  • Exchange
  • AZTA Nasdaq
  • JBGS Nasdaq
  • Market Cap
  • AZTA 1.4B
  • JBGS 1.4B
  • IPO Year
  • AZTA 1995
  • JBGS 2017
  • Fundamental
  • Price
  • AZTA $34.43
  • JBGS $19.54
  • Analyst Decision
  • AZTA Buy
  • JBGS Sell
  • Analyst Count
  • AZTA 3
  • JBGS 2
  • Target Price
  • AZTA $45.00
  • JBGS $16.00
  • AVG Volume (30 Days)
  • AZTA 954.7K
  • JBGS 816.6K
  • Earning Date
  • AZTA 08-05-2025
  • JBGS 07-29-2025
  • Dividend Yield
  • AZTA N/A
  • JBGS 3.62%
  • EPS Growth
  • AZTA N/A
  • JBGS N/A
  • EPS
  • AZTA N/A
  • JBGS N/A
  • Revenue
  • AZTA $669,171,000.00
  • JBGS $520,825,000.00
  • Revenue This Year
  • AZTA N/A
  • JBGS N/A
  • Revenue Next Year
  • AZTA $4.88
  • JBGS $2.71
  • P/E Ratio
  • AZTA N/A
  • JBGS N/A
  • Revenue Growth
  • AZTA 8.56
  • JBGS N/A
  • 52 Week Low
  • AZTA $23.91
  • JBGS $13.28
  • 52 Week High
  • AZTA $63.58
  • JBGS $19.58
  • Technical
  • Relative Strength Index (RSI)
  • AZTA 62.82
  • JBGS 73.67
  • Support Level
  • AZTA $31.27
  • JBGS $17.93
  • Resistance Level
  • AZTA $35.33
  • JBGS $19.27
  • Average True Range (ATR)
  • AZTA 1.60
  • JBGS 0.51
  • MACD
  • AZTA 0.08
  • JBGS 0.13
  • Stochastic Oscillator
  • AZTA 79.87
  • JBGS 97.66

About AZTA Azenta Inc.

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.

About JBGS JBG SMITH Properties

JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party asset management and real estate services. It generates maximum revenue from the commercial segment.

Share on Social Networks: